NCAN and ANO4 are also upregulated in the PL-NAWM of chronic active MS lesions compared to the PL-NAWM of inactive lesions (comparison II; fold change of 2.7 and 2.1) (Figure 2). This evidence concerns the gene NCAN and myeloid sarcoma.